GPCM
ETRM

Granite Point Capital Management’s EnteroMedics Inc. ETRM Stock Holding History

Granite Point Capital Management’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-124
Closed -$203K – 117
2014
Q2 		$203K Sell
124
-47
-27% -$87.9K 0.14% 86
2014
Q1 		$328K Sell
171
-43
-20% -$102K 0.23% 93
2013
Q4 		$459K Buy
+214
New +$345K 0.08% 87

Other funds holding ETRM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Granite Point Capital Management's ETRM Position: Q3 2014 in Review

Granite Point Capital Management sold out of EnteroMedics Inc. (ETRM) in Q3 2014, closing a stake of 124 shares — an estimated $203K sold.

Granite Point Capital Management first reported a position in ETRM in Q4 2013 and held it in 3 quarters. The position peaked at $459K in Q4 2013. 49 funds tracked by Wall St. Rank hold ETRM as of Q3 2014.

  • Granite Point Capital Management reported no remaining EnteroMedics Inc. position as of Q3 2014 after selling out during the quarter.
  • Granite Point Capital Management sold 124 EnteroMedics Inc. shares in Q3 2014, an estimated $203K.
  • Granite Point Capital Management first reported a position in EnteroMedics Inc. in Q4 2013 and held it in 3 quarters.
  • Granite Point Capital Management's EnteroMedics Inc. position peaked at $459K in Q4 2013.
  • 49 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q3 2014.

Based on Granite Point Capital Management's 13F filing for Q3 2014, filed 13 Nov 2014.